Vanesa Pomeranz

TL;DR: Patients with Fabry disease display heavy podocyturia; those untreated present significantly higher podocyTuria, lower proteinuria and better renal function than those who are treated, suggesting that therapy may be started at advanced stages.

TL;DR: AKI was associated with pregnancy, immunosuppression, high APAC HE, SOFA and MURRA Y scores, and less time on mechanical ventilation assistance, hemodynamical instability and thrombocytopenia.

TL;DR: In controls and at early stages of CKD, creatinine-based equations correlated better with (99m)Tc-DTPA, with CKD-EPI being the one with the best degree of agreement.

TL;DR: It is demonstrated that podocyturia antedates the classical appearance of proteinuria and could be considered as an even earlier biomarker of kidney damage.

TL;DR: Fabry disease is characterized by early occurrence of increased uCD80 excretion that appears to be a consequence of glycolipid accumulation, and the potential for uCD 80 excretion to reflect early, subclinical renal Fabry involvement should be further studied.